SGA
SUPN icon

Seaport Global Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Seaport Global Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,069
Closed -$548K – 58
2024
Q1 		$548K Hold
16,069
– – 1.11% 37
2023
Q4 		$465K Buy
16,069
+8,127
+102% +$215K 1.11% 44
2023
Q3 		$219K Buy
7,942
+3,346
+73% +$102K 0.66% 55
2023
Q2 		$138K Hold
4,596
– – 0.41% 82
2023
Q1 		$167K Sell
4,596
-3,431
-43% -$132K 0.53% 79
2022
Q4 		$286K Buy
+8,027
New +$279K 0.99% 36

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Seaport Global Advisors's SUPN Position: Q2 2024 in Review

Seaport Global Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q2 2024, closing a stake of 16,069 shares — an estimated $548K sold.

Seaport Global Advisors first reported a position in SUPN in Q4 2022 and held it in 6 quarters. The position peaked at $548K in Q1 2024. 245 funds tracked by Wall St. Rank hold SUPN as of Q2 2024.

  • Seaport Global Advisors reported no remaining Supernus Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Seaport Global Advisors sold 16,069 Supernus Pharmaceuticals shares in Q2 2024, an estimated $548K.
  • Seaport Global Advisors first reported a position in Supernus Pharmaceuticals in Q4 2022 and held it in 6 quarters.
  • Seaport Global Advisors's Supernus Pharmaceuticals position peaked at $548K in Q1 2024.
  • 245 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2024.

Based on Seaport Global Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.